跳到正文

Seven Fleet Capital Management LP 13F 持仓 · 2026年Q2

Seven Fleet Capital Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 96 只证券,申报市值合计 6.06 亿美元。前几大持仓:CGON(22.12%)、TNGX(15.79%)、RVMD(7.48%)。本季前 25 大持仓中:新建仓 2 只、增持 22 只、减持 1 只。

排名代码公司市值占组合股数变动
1CGONCG ONCOLOGY INC$134.0M22.12%1.9M增持
2TNGXTANGO THERAPEUTICS INC$95.7M15.79%3.2M增持
3RVMDREVOLUTION MEDICINES INC$45.3M7.48%242,029增持
4PHVSPHARVARIS N V$26.8M4.42%774,501增持
5LQDALIQUIDIA CORPORATION$20.5M3.38%256,603增持
6ELVNENLIVEN THERAPEUTICS INC$18.5M3.06%365,386增持
7ABVXABIVAX SA$14.8M2.45%111,334增持
8AVTXAVALO THERAPEUTICS INC$14.2M2.35%770,765增持
9MIRMMIRUM PHARMACEUTICALS INC$12.9M2.13%110,393新建仓
10ASMBASSEMBLY BIOSCIENCES INC$11.9M1.96%433,147增持
11IPSCCENTURY THERAPEUTICS INC$10.7M1.76%4.3M增持
12CYTKCYTOKINETICS INC$10.1M1.66%118,240增持
13TSHATAYSHA GENE THERAPIES INC$9.9M1.64%1.5M增持
14MANEVERADERMICS INC$9.8M1.62%80,000新建仓
15AVBPARRIVENT BIOPHARMA INC$8.6M1.41%246,606增持
16TARSTARSUS PHARMACEUTICALS INC$7.9M1.31%117,067增持
17ROIVROIVANT SCIENCES LTD$7.8M1.29%220,126增持
18XNCRXENCOR INC$7.8M1.29%368,305增持
19DMRADAMORA THERAPEUTICS INC$7.4M1.22%284,430增持
20AXSMAXSOME THERAPEUTICS INC$7.1M1.16%28,826增持
21DFTXDEFINIUM THERAPEUTICS INC$7.0M1.15%148,647增持
22DNTHDIANTHUS THERAPEUTICS INC$6.3M1.04%64,723增持
23COGTCOGENT BIOSCIENCES INC$5.7M0.94%147,510减持
24ERASERASCA INC$5.6M0.93%308,007增持
25NERVMINERVA NEUROSCIENCES INC$5.6M0.92%1.0M增持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR